Difference between revisions of "Template:Adenosinergics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Vanished 45kd09la13
m (79 revisions imported)
 
(51 intermediate revisions by 21 users not shown)
Line 1: Line 1:
{{Navbox
+
#REDIRECT [[Template:Purine receptor modulators]]
| name  = Adenosinergics
 
| title = [[Adenosine]]rgics
 
| groupstyle = background-color: LightYellow
 
| state = collapsed
 
 
 
  | group1 = [[Receptor (biochemistry)|Receptor]] [[Ligand]]s
 
  |  list1 = {{Navbox subgroup
 
  | groupstyle = background-color: LightYellow
 
 
 
    | group1 = [[Agonist]]s
 
    | list1  = [[2-(1-Hexynyl)-N-methyladenosine]] • [[2-Cl-IB-MECA]] • [[2'-MeCCPA]] • [[5'-N-ethylcarboxamidoadenosine]] • [[ATL-146e]] • [[BAY 60–6583]] • [[CCPA (biochemistry)|CCPA]] • [[CF-101]] (IB-MECA) • [[CGS-21680]] • [[CP-532,903]] • [[GR 79236]] • [[LUF-5835]] • [[LUF-5845]] • [[MRS-3558]] • [[N6-Cyclopentyladenosine]] • [[Regadenoson]] • [[SDZ WAG 994]]
 
 
 
    | group2 = [[Receptor antagonist|Antagonist]]s
 
    | list2  = [[8-Phenyl-1,3-dipropylxanthine]] • [[Acefylline]] • [[Bamifylline]] • [[Caffeine]] • [[Chlorotheophylline]] • [[8-Cyclopentyl-1,3-dimethylxanthine|CPX]] • [[CVT-6883]] • [[Cyclopentyltheophylline‎]] • [[8-Cyclopentyl-1,3-dipropylxanthine‎|DPCPX]] • [[Istradefylline]] • [[KF-26777]] • [[MRE3008F20]] • [[MRS-1191]] • [[MRS-1220]] • [[MRS-1334]] • [[MRS-1523]] • [[MRS-1706]] • [[MRS-1754]] • [[MRS-3777]] • [[Paraxanthine]] • [[Preladenant]] • [[PSB-10]] • [[PSB-11]] • [[PSB 36]] • [[PSB-603]] • [[PSB-788]] • [[PSB-1115]] • [[Rolofylline]] • [[SCH-442,416]] • [[SCH-58261]] • [[Theophylline]] • [[VUF-5574]] • [[ZM-241,385]]
 
 
 
  }}
 
 
 
  | group2 = [[Reuptake_inhibitor|Reuptake Inhibitor]]s
 
  | list2  = {{Navbox subgroup
 
  | groupstyle = background-color: LightYellow
 
 
 
    | group1 = [[Plasmalemmal]]
 
    | list1  = {{Navbox subgroup
 
    | groupstyle = background-color: LightYellow
 
 
 
      | group1 = [[Equilibrative nucleoside transporter|ENT]] Inhibitors
 
      | list1  = [[Dilazep]] • [[Dipyridamole]] • [[Hexobendine]] • [[Pentoxifylline]] • [[Propentofylline]]
 
 
 
    }}
 
 
 
    | group2 = [[Vesicular]]
 
    | list2  = {{Navbox subgroup
 
    | groupstyle = background-color: LightYellow
 
 
 
      | group1 = [[Vesicular nucleotide transporter|VNT]] Inhibitors
 
      | list1  = .....
 
 
 
    }}
 
 
 
  }}
 
 
 
  <!--
 
  | group3 = [[Enzyme_inhibitor|Enzyme Inhibitor]]s
 
  | list3  = {{Navbox subgroup
 
  | groupstyle = background-color: LightYellow
 
 
 
    | group1 = [[Anabolism]]
 
    | list1  = {{Navbox subgroup
 
    | groupstyle = background-color: LightYellow
 
 
 
      | group1 = .....
 
      | list1  = .....
 
 
 
    }}
 
 
 
    | group2 = [[Catabolism]]
 
    | list2  = {{Navbox subgroup
 
    | groupstyle = background-color: LightYellow
 
 
 
      | group1 = .....
 
      | list1  = .....
 
 
 
    }}
 
 
 
  }}
 
 
 
  | group5 = Others
 
  |  list5 = {{Navbox subgroup
 
  | groupstyle = background-color: LightYellow
 
 
 
    | group1 = [[Precursor_(chemistry)|Precursor]]s
 
    | list1  = .....
 
 
 
    | group2 = [[Cofactor (biochemistry)|Cofactor]]s
 
    | list2  = .....
 
 
 
    | group3 = Others
 
    | list3  = .....
 
 
 
  }}
 
  -->
 
 
 
}}
 
<noinclude>
 
[[Category:Biochemistry templates|{{PAGENAME}}]]
 
</noinclude>
 

Latest revision as of 05:49, 17 October 2020